Ogilvie syndrome medical therapy: Difference between revisions

	Ogilvie syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ogilvie syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ogilvie syndrome medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ogilvie syndrome medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ogilvie syndrome medical therapy
CDC on Ogilvie syndrome medical therapy
Ogilvie syndrome medical therapy in the news
Blogs on Ogilvie syndrome medical therapy
Directions to Hospitals Treating Ogilvie syndrome
Risk calculators and risk factors for Ogilvie syndrome medical therapy

Revision as of 20:28, 5 February 2018

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 1: / Line 1: @@
 __NOTOC__
 Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 {{Ogilvie syndrome}}
@@ Line 5: / Line 6: @@
 ==Overview==
 ==Medical Therapy==
-It usually resolves with conservative therapy stopping oral ingestions, i.e. [[nil per os]] and a [[Feeding tube|nasogastric tube]], but may require [[colonoscopy|colonoscopic]] decompression which is successful in 70% of the cases. A study published in the [[New England Journal of Medicine]] showed that [[neostigmine]] is a potent pharmacological way of decompressing the colon. According to the American Society for Gastrointestinal Endoscopy (ASGE), it should be considered prior to colonoscopic decompression. The use of neostigmine is not without risk since it can induce bradyarrhythmia and bronchospasms. Therefore atropine should be within immediate reach when this therapy is used.
 ==References==
 {{reflist|2}}
 [[Category:Needs content]]